APA (7th ed.) Citation

Heublein, S., Friese, K., Kost, B., Marmé, F., Kuhn, C., Mahner, S., . . . Vattai, A. (2018). TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer. Journal of cancer research and clinical oncology, 144(10), . https://doi.org/10.1007/s00432-018-2706-5

Chicago Style (17th ed.) Citation

Heublein, Sabine, et al. "TA-MUC1 as Detected by the Fully Humanized, Therapeutic Antibody Gatipotzumab Predicts Poor Prognosis in Cervical Cancer." Journal of Cancer Research and Clinical Oncology 144, no. 10 (2018). https://doi.org/10.1007/s00432-018-2706-5.

MLA (9th ed.) Citation

Heublein, Sabine, et al. "TA-MUC1 as Detected by the Fully Humanized, Therapeutic Antibody Gatipotzumab Predicts Poor Prognosis in Cervical Cancer." Journal of Cancer Research and Clinical Oncology, vol. 144, no. 10, 2018, https://doi.org/10.1007/s00432-018-2706-5.